drugset / Trial / NCT00000115

Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema

NCT00000115

Phase 2 Completed National Eye Institute (NEI)
RandomizedCrossoverDouble-blindTreatment

Summary

To test the efficacy of acetazolamide for the treatment of uveitis-associated cystoid macular edema.

Timeline

Start
1990-12
Primary completion
Completion
1994-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 500 mg Oral

Indications